Report LibraryAll Reports
Market Spotlight: Myelofibrosis
Retail Price: $16,500.00*BioMedTracker Subscriber Price: $11,250.00 - click here to log in
October 06, 2017Myelofibrosis is a myeloproliferative neoplasm, which can exist as a primary disease known as primary myelofibrosis, or can evolve to post- polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis from PV or ET. It is characterized by the buildup of scar tissue (fibrosis) in bone marrow, which leads to a reduction in blood cell production.
This Datamonitor Healthcare report contains a Market Spotlight module.
|Indications Covered:||Myelofibrosis (MF)|